Crystallography Open Database
Search results
Result: there are 51 entries in the selection
Switch to the old layout of the pageDownload all results as: list of COD numbers | list of CIF URLs | data in CSV format | archive of CIF files (ZIP)
Searching journal of publication like 'Molecular pharmaceutics' volume of publication is 12
COD ID  |
Links | Formula  |
Space group |
Cell parameters | Cell volume |
Bibliography |
|---|---|---|---|---|---|---|
| 1519620 | CIF | C23 H29 N3 O6 | P 1 21 1 | 9.7456; 10.052; 12.315 90; 107.912; 90 | 1147.93 | Maguire, Courtney K.; Brunskill, Andrew P. J. Assessment of the Stoichiometry of Multicomponent Crystals Using Only X-ray Powder Diffraction Data. Molecular pharmaceutics, 2015, 12, 2061-2067 |
| 1519621 | CIF | C22 H27 N3 O6 | P 1 21 1 | 9.4995; 9.7624; 12.7614 90; 111.666; 90 | 1099.86 | Maguire, Courtney K.; Brunskill, Andrew P. J. Assessment of the Stoichiometry of Multicomponent Crystals Using Only X-ray Powder Diffraction Data. Molecular pharmaceutics, 2015, 12, 2061-2067 |
| 1520674 | CIF | C28 H33 N3 Na O10 Re S | P 1 21/c 1 | 31.609; 10.4939; 9.2829 90; 96.146; 90 | 3061.5 | Jia, Jianhua; Cui, Mengchao; Dai, Jiapei; Liu, Boli (99m)Tc(CO)3-Labeled Benzothiazole Derivatives Preferentially Bind Cerebrovascular Amyloid: Potential Use as Imaging Agents for Cerebral Amyloid Angiopathy. Molecular pharmaceutics, 2015, 12, 2937-2946 |
| 1520723 | CIF | C22 H29 N3 O5 | P 1 21/c 1 | 13.212; 9.1505; 18.16 90; 105.195; 90 | 2118.7 | Braun, Doris E.; Koztecki, Lien H.; McMahon, Jennifer A.; Price, Sarah L.; Reutzel-Edens, Susan M Navigating the Waters of Unconventional Crystalline Hydrates. Molecular pharmaceutics, 2015, 12, 3069-3088 |
| 1520724 | CIF | C22 H28.46 N3 O4.73 | C 1 2/c 1 | 26.498; 9.6469; 20.342 90; 128.706; 90 | 4057.8 | Braun, Doris E.; Koztecki, Lien H.; McMahon, Jennifer A.; Price, Sarah L.; Reutzel-Edens, Susan M Navigating the Waters of Unconventional Crystalline Hydrates. Molecular pharmaceutics, 2015, 12, 3069-3088 |
| 1520725 | CIF | C22 H28.9 N3 O4.95 | C 1 2/c 1 | 26.663; 9.634; 20.863 90; 128.322; 90 | 4204 | Braun, Doris E.; Koztecki, Lien H.; McMahon, Jennifer A.; Price, Sarah L.; Reutzel-Edens, Susan M Navigating the Waters of Unconventional Crystalline Hydrates. Molecular pharmaceutics, 2015, 12, 3069-3088 |
| 1547408 | CIF | C11 H12 N4 O2 S | P n a 21 | 14.4393; 8.1764; 21.7395 90; 90; 90 | 2566.6 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547409 | CIF | C11 H12 N4 O2 S | P n a 21 | 14.4687; 8.1829; 21.8084 90; 90; 90 | 2582 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547410 | CIF | C11 H12 N4 O2 S | P n a 21 | 14.4829; 8.1938; 21.8441 90; 90; 90 | 2592.24 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547411 | CIF | C11 H12 N4 O2 S | P n a 21 | 14.4899; 8.2086; 21.9106 90; 90; 90 | 2606.09 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547412 | CIF | C11 H12 N4 O2 S | P n a 21 | 14.4902; 8.2249; 22.0106 90; 90; 90 | 2623.2 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547413 | CIF | C11 H12 N4 O2 S | P n a 21 | 14.4588; 8.18; 21.7664 90; 90; 90 | 2574.38 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547414 | CIF | C11 H12 N4 O2 S | P n a 21 | 14.4597; 8.1802; 21.7812 90; 90; 90 | 2576.35 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547415 | CIF | C11 H12 N4 O2 S | P n a 21 | 14.4638; 8.1835; 21.7953 90; 90; 90 | 2579.79 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547416 | CIF | C11 H12 N4 O2 S | P n a 21 | 14.4666; 8.1868; 21.8103 90; 90; 90 | 2583.11 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547417 | CIF | C11 H12 N4 O2 S | P n a 21 | 14.4701; 8.1889; 21.8216 90; 90; 90 | 2585.73 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547418 | CIF | C11 H12 N4 O2 S | P n a 21 | 14.4734; 8.1921; 21.8397 90; 90; 90 | 2589.48 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547419 | CIF | C11 H12 N4 O2 S | P n a 21 | 14.4763; 8.1946; 21.8522 90; 90; 90 | 2592.27 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547420 | CIF | C11 H12 N4 O2 S | P n a 21 | 14.4795; 8.1974; 21.8693 90; 90; 90 | 2595.76 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547421 | CIF | C11 H12 N4 O2 S | P n a 21 | 14.4814; 8.1993; 21.8844 90; 90; 90 | 2598.5 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547422 | CIF | C11 H12 N4 O2 S | P n a 21 | 14.4852; 8.202; 21.9002 90; 90; 90 | 2601.91 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547423 | CIF | C11 H12 N4 O2 S | P n a 21 | 14.4884; 8.2048; 21.9167 90; 90; 90 | 2605.34 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547424 | CIF | C11 H12 N4 O2 S | P n a 21 | 14.4914; 8.2069; 21.9332 90; 90; 90 | 2608.5 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547425 | CIF | C11 H12 N4 O2 S | P n a 21 | 14.495; 8.2094; 21.9489 90; 90; 90 | 2611.81 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547426 | CIF | C11 H12 N4 O2 S | P n a 21 | 14.4973; 8.2118; 21.9658 90; 90; 90 | 2615 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547427 | CIF | C11 H12 N4 O2 S | P n a 21 | 14.5008; 8.2141; 21.9821 90; 90; 90 | 2618.31 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547428 | CIF | C11 H12 N4 O2 S | P n a 21 | 14.504; 8.2162; 21.9984 90; 90; 90 | 2621.5 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547429 | CIF | C11 H12 N4 O2 S | P b c a | 9.0785; 11.5265; 22.8581 90; 90; 90 | 2391.95 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547430 | CIF | C11 H12 N4 O2 S | P b c a | 9.0963; 11.5574; 22.8612 90; 90; 90 | 2403.39 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547431 | CIF | C11 H12 N4 O2 S | P b c a | 9.0885; 11.5482; 22.7898 90; 90; 90 | 2391.9 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547432 | CIF | C11 H12 N4 O2 S | P b c a | 9.0907; 11.5779; 22.8104 90; 90; 90 | 2400.82 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547433 | CIF | C11 H12 N4 O2 S | P b c a | 9.1074; 11.6193; 22.8456 90; 90; 90 | 2417.56 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547434 | CIF | C11 H12 N4 O2 S | P b c a | 9.1228; 11.6522; 22.8488 90; 90; 90 | 2428.8 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547435 | CIF | C11 H12 N4 O2 S | P b c a | 9.1349; 11.6868; 22.866 90; 90; 90 | 2441.12 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547436 | CIF | C11 H12 N4 O2 S | P b c a | 9.0823; 11.5422; 22.8439 90; 90; 90 | 2394.72 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547437 | CIF | C11 H12 N4 O2 S | P b c a | 9.0881; 11.5538; 22.8478 90; 90; 90 | 2399.07 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547438 | CIF | C11 H12 N4 O2 S | P b c a | 9.0992; 11.5635; 22.8525 90; 90; 90 | 2404.51 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547439 | CIF | C11 H12 N4 O2 S | P b c a | 9.0972; 11.5751; 22.8531 90; 90; 90 | 2406.45 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547440 | CIF | C11 H12 N4 O2 S | P b c a | 9.1048; 11.5802; 22.8576 90; 90; 90 | 2410 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547441 | CIF | C11 H12 N4 O2 S | P b c a | 9.1064; 11.5845; 22.8569 90; 90; 90 | 2411.25 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547442 | CIF | C11 H12 N4 O2 S | P b c a | 9.107; 11.5902; 22.8593 90; 90; 90 | 2412.84 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547443 | CIF | C11 H12 N4 O2 S | P b c a | 9.1066; 11.5983; 22.8627 90; 90; 90 | 2414.78 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547444 | CIF | C11 H12 N4 O2 S | P b c a | 9.1158; 11.6222; 22.8715 90; 90; 90 | 2423.14 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547445 | CIF | C11 H12 N4 O2 S | P b c a | 9.12; 11.6339; 22.8697 90; 90; 90 | 2426.5 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547446 | CIF | C11 H12 N4 O2 S | P b c a | 9.1237; 11.6442; 22.8738 90; 90; 90 | 2430.07 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547447 | CIF | C11 H12 N4 O2 S | P b c a | 9.128; 11.6579; 22.8759 90; 90; 90 | 2434.3 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547448 | CIF | C11 H12 N4 O2 S | P b c a | 9.1311; 11.6667; 22.88 90; 90; 90 | 2437.4 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547449 | CIF | C11 H12 N4 O2 S | P b c a | 9.1357; 11.6782; 22.8834 90; 90; 90 | 2441.4 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547450 | CIF | C11 H12 N4 O2 S | P b c a | 9.1405; 11.6923; 22.8838 90; 90; 90 | 2445.67 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
| 1547451 | CIF | C11 H12 N4 O2 S | P b c a | 9.1415; 11.7002; 22.8837 90; 90; 90 | 2447.58 | Anuradha R. Pallipurath; Jonathan M. Skelton; Mark R. Warren; Naghmeh Kamali; Patrick McArdle; Andrea Erxleben Sulfamerazine: Understanding the Influence of Slip Planes in the Polymorphic Phase Transformation through X-Ray Crystallographic Studies and ab Initio Lattice Dynamics Molecular Pharmaceutics, 2015, 12, 3735-3748 |
Back to the search form
Your own data is not in the COD? Deposit it, thanks!